> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within a population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate, in eaerly 2020.

> Testing for antibodies in India in May/Jun 2021, indicated that
> Covid 19 exposure was present in 67% of test subjects. This
> compared to a 7% figure recorded in the fall of 2020. A daily
> infection rate in excess of 2000ppm is suggested by this change.

> http://tiny.cc/cn8muz

>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>

> Comparison charts, as of Nov 30 are available:

> http://ve3ute.ca/query/211130_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/211130_cases_daily_ppm_report_group.jpg

> http://ve3ute.ca/query/211130_deaths_report_group.jpg
> http://ve3ute.ca/query/211130_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/211130_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/211130_deaths_daily_greater_than_5ppm.jpg

> http://ve3ute.ca/query/211130_vaccine_doses_report_group.jpg
> http://ve3ute.ca/query/211130_vaccine_doses_daily_report_group.jpg
> http://ve3ute.ca/query/211130_vaccinations_completed_report_group.jpg

Flu Season? Fatality comparison to past events in the U.S.A.
Updated Dec 31 to include a second year trend or 'season'.

http://ve3ute.ca/query/flu_season_028b.jpg

> Looks like everyone's going to get it, eventually, vaccinated
> or not - just reduced mortality amongst the vaccinated.

As of Jan03:
US detections are at 165529ppm.(16.5%)
Detection rate is 1212ppm/day and rising to exceed testing capacity.
Fatalities are 2481ppm at 3.8ppm/day.
FR is 1.6% from a 157040ppm detection recorded 7 days previously.
FR ten day short term is 0.7%
US test rate is 4120ppm/day
29.4% of current tests are positive.
Vaccinations at 153% at 1300ppm/day
- with 62% fully vaccinated.

Canada detections at 58553ppm (5.9%) ~ 371 days behind the US.
Detection rate at 875ppm/day and rising to exceed testing capacity.
Fatalities are 799ppm at 0.7ppm/day. ~ 400 days behind the US.
FR is 1.5% from a 52428ppm detection recorded 7 days previously.
Case FR ten day short term is 0.2% .
Canada test rate is 4030ppm/day
21.7% of current tests are positive.
Vaccinations at 181% at 5900ppm/day
- with 77% fully vaccinated.

Italy detections at 104826ppm. (10.5%)
Detection rate is 1611ppm/day and rising.
Fatalities are 2280ppm at 2.5ppm/day.
FR is 2.4% from a 93549ppm detection recorded 7 days previously.
Case FR ten day short term is 0.5% .
Italy test rate is 13430ppm/day.
12.0% of current tests are positive.
Vaccinations at 184% at 7000ppm/day
- with 74% fully vaccinated.

Sweden detections at 129406ppm (12.9%)
Detection rate is 583ppm/day and rising.
Fatalities are 1507ppm at 0.6ppm/day.
FR is 1.2% from a 125324ppm detection recorded 7 days previously.
Case FR ten day short term is 0.2% .
Sweden test rate is 4880ppm/day.
11.9% of current tests are positive.
Vaccinations are at 173% at 2800ppm/day
- with 73% fully vaccinated.

UK detections at 194450ppm. (19.4%)
Detection rate is 2823ppm/day and rising.
Fatalities are 2184ppm at 2.1ppm/day.
FR is 1.3% from a 172901ppm detection recorded 7 days previously.
Case FR ten day short term is 0.2% .
UK test rate is 20600ppm/day.
13.7% of current tests are positive.
Vaccinations at 195% at 3600ppm/day
- with 70% fully vaccinated.

Brazil detections at 104197ppm. (10.4%)
Detection rate is 36ppm/day and rising.
Fatalities are 2894ppm at 0.5ppm/day
FR is 2.8% from an 103904ppm detection recorded 7 days previously.
Case FR ten day short term is 3.1% .
Brazil test rate is 230ppm/day.
15.6 of current tests are positive%.
Vaccinations at 155% at 1700ppm/day
- with 67% fully vaccinated.

Peru detections at 68981ppm. (6.9%)
Detection rate is 96ppm/day and rising.
Fatalities are 6077ppm at 1.1ppm/day.
FR is 8.9% from a 68311ppm detection recorded 7 days previously.
Case FR ten day short term is 1.9% .
Peru test rate is 330ppm/day.
No test positivity rate is practical.
Vaccinations at 148% at 4900ppm/day
- with 64% fully vaccinated

Chile detections at 94226ppm (9.4%)
Detection rate is 75ppm/day and rising.
Fatalities are 2038ppm at 1.0ppm/day.
FR is 2.2% from a 93262ppm detection recorded 14 days previously.
Case FR ten day short term is 1.5% .
Chile test rate is 2540ppm/day.
3.0% of current tests are positive.
Vaccinations at 230% at 5700ppm/day
- with 86.0% fully vaccinated.

Argentina detections at 124873ppm (12.5%)
Detection rate is 736ppm/day and rising to exceed testing capacity.
Fatalities are 2570ppm at 0.5ppm/day.
FR is 2.1% from a 119722ppm detection recorded 7 days previously.
Case FR ten day short term is 0.8% .
Argentina test rate is 2110ppm/day.
34.9% of current tests are positive.
Vaccinations at 168% at 6000ppm/day
- with 72% fully vaccinated.

Mexico detections at 30622ppm (3.1%)
Detection rate is 42ppm/day and rising to exceed testing capacity.
Fatalities are 2299ppm at 0.8ppm/day.
FR is 7.6% from a 30325ppm detection recorded 7 days previously.
Case FR ten day short term is 5.8% .
Mexico test rate is 120ppm/day.
No test positivity rate is practical.
Vaccinations at 114% at 400ppm/day
- with 56% fully vaccinated.

South Africa detections at 57833ppm (5.8%)
Detection rate is 140ppm/day and falling.
Fatalities are 1519ppm at 1.0ppm/day.
FR is 2.7% from a 56853ppm detection recorded 7 days previously.
Case FR ten day short term is 0.4% .
SA test rate is 650ppm/day.
21.5% of current tests are positive.
Vaccinations at 47% at 400ppm/day
- with 26% fully vaccinated.(a rounding error?)

Czech detections at 231416ppm (23.1%)
Detection rate is 481ppm/day and falling.
Fatalities are 3377ppm at 6.3ppm/day.
FR is 1.5% from a 228051ppm detection recorded 7 days previously.
Case FR ten day short term is 1.7% .
Czech test rate is 4570ppm/day.
10.5% of current tests are positive.
Vaccinations at 144% at 3500ppm/day
- with 62% fully vaccinated.

India detections at 25063ppm (2.5%)
Detection rate is 13ppm/day and level below 20ppm/day.
Fatalities at 346ppm at 0.2ppm/day.
FR is 1.4% from a 24970ppm detection recorded 7 days previously.
Case FR ten day short term is 4.1% .
India test rate 800ppm/day.
1.6% of current tests are positive.
Vaccinations at 104% at 4100ppm/day
- with 44% fully vaccinated.

Israel detections at 150157ppm (15.0%)
Detection rate is 464ppm/day and rising.
Fatalities at 887ppm at 0.0ppm/day.
FR is 0.6% from a 146921ppm detection recorded 7 days previously.
Case FR ten day short term is 0.0% .
Israel test rate is 14010ppm/day.
3.3% of current tests are positive
Vaccinations at 180% at 2400ppm/day.
- with 64% fully vaccinated.

Fatality rate hotspots (>5ppm/day) :

Trinidad and Tobago - 14.9ppm/day
Georgia - 14.1ppm/day
Poland - 12.3ppm/day
Croatia - 9.9ppm/day
Bulgaria - 9.4ppm/day
Slovakia - 7.9ppm
Bosnia - 7.6ppm/day
Lithuania - 7.1ppm/day
Greece - 6.9ppm/day
Czechia - 6.3ppm/day
Russia - 6.0ppm/day
Latvia - 5.8ppm/day

> Doses applied in Israel, Chile and other highly vaccinated countries
> appear to be providing 3rd dose booster reinforcement, without
> contributing to completed vaccinations.

> Full vaccination levels are apparently stalled around 60% in the US
> and other regions with signifigant reactionary movements.

> The increased transmissibility of omicron variants have contributed
> to the rise in detections, world-wide, after Nov 2021. So far, no
> increase in mortality is associated with this variant.

> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>

> Reducing detections and fatalities in unvaccinated India/Nepal
> seem to indicate reducing virulence for the delta variant.
> Detection rates in S.Africa had also turned around until the
> recent influences of the omicron variant. So far there is no
> corresponding increase in fatalities.

RL